14 Paid Clinical Research Studies in Mobile, Alabama
Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination
The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunogenicity of CHIKV VLP vaccine in
📍 Alliance for Multispecialty Research, LLC — Mobile, Alabama
View Study & Checklist ➔A Trial of Vigil for Participants With Ovarian Cancer
The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated with investigational product (Vigil) compared to p
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
💵 Participants will receive Vigil or placebo by intradermal injection once a month for at least 4 and up to a maximum of 6
View Study & Checklist ➔Abemaciclib and Letrozole to Treat Endometrial Cancer
This is a phase II single arm trial to determine the percentage of patients without evidence of disease progression on abemaciclib and letrozole in advanced stage, persistent or re
📍 University of South Alabama Mitchell Cancer Center — Mobile, Alabama
💵 Patients must have adequate organ and marrow function as defined below NOTE: Institutional/laboratory upper limit of nor
View Study & Checklist ➔A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults
This study will assess the pharmacokinetics (PK), safety, and tolerability of CAB ULA administered every 4 months (Q4M) following administration of CAB LA every 2 months (Q2M), in
📍 GSK Investigational Site — Mobile, Alabama
View Study & Checklist ➔A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
The purpose of this study is to evaluate the long-term safety and clinical status of pediatric patients with Inflammatory Bowel Disease (IBD). Particular attention will be directed
📍 Clinical Research Facility — Mobile, Alabama
💵 All patients will receive standard-of-care treatments prescribed by the patient's physician.
View Study & Checklist ➔Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
The purpose of this study is to assess the safety, reactogenicity, immunogenicity and long-term persistence of immune response up to 5 years following a single dose vaccination of
📍 GSK Investigational Site — Mobile, Alabama
View Study & Checklist ➔A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic Follicular Lymphoma is a slow-growing t
📍 Infirmary Health - Infirmary Cancer Care at Mobile Infirmary /ID# 264630 — Mobile, Alabama
💵 Participants will receive escalating doses of epcoritamab, until full dose is achieved.
View Study & Checklist ➔A Study to Evaluate Solriktug in Adult Participants With Asthma
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.
📍 Velocity Clinical Research — Mobile, Alabama
💵 Participants will receive solrikitug, or placebo, administered via subcutaneous injection at the study site, over a 12-w
View Study & Checklist ➔Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjec
📍 University of South Alabama — Mobile, Alabama
💵 It is a single-arm study and all subjects will receive OviTex.
View Study & Checklist ➔A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
The purpose of this study is to assess the consistency of immune response to three different lots of GSK's investigational varicella vaccine (VNS Vaccine), and to compare the safet
📍 GSK Investigational Site — Mobile, Alabama
View Study & Checklist ➔Caris Biorepository Research Protocol
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancin
📍 University of South Alabama — Mobile, Alabama
View Study & Checklist ➔Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) versus B
📍 Clinical Study Site — Mobile, Alabama
💵 Each enrolled subject will receive an intravenous infusion of the Ivonescimab/Bevacizumab Plus mFOLFOX6 (Q2W, up to 8 cy
View Study & Checklist ➔A Study to Learn About mRNA Vaccines Against Influenza in Adults
The purpose of this study is to learn about safety in participants taking the study vaccine (mRNA-based vaccine) and the ability of the study vaccine to trigger the body's immune r
📍 AMR Clinical — Mobile, Alabama
View Study & Checklist ➔A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive
📍 University of Alabama - Strada Patient Care Center, Neurology — Mobile, Alabama
💵 Eligible subjects will have up to 9.5 weeks durations to assess the baseline frequency of seizures, followed by a double
View Study & Checklist ➔